Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Immunocore Holdings plc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 47 | 1 | 49 | +3 |
| Shares | 16.7M | 25.1K | 17.7M | +1.08M (+6.5%) |
| Value | $617.4M | $932.0K | $642.4M | +$26.0M (+4.2%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Immunocore Holdings plc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Velan Capital Investment Management LP | 293,385 | $10.0M | 8.39% |
| Rathbone Brothers plc | 190,015 | $6.51M | 0.06% |
| Paradigm Biocapital Advisors LP | 134,249 | $4.60M | 1.31% |
| Vident Investment Advisory, LLC | 30,676 | $1.05M | 0.03% |
| Marshall Wace, LLP | 24,120 | $826.0K | 0.00% |
| Rockefeller Capital Management L.P. | 1,000 | $34.0K | 0.00% |
| Veritas Investment Partners (UK) Ltd. | 575 | $20.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 19 | $1.00K | 0.00% |
| Kayne Anderson Rudnick Investment Management LLC | 3 | $0 | 0.00% |
Sold out (6)
Institutions that held Immunocore Holdings plc at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Millennium Management LLC | 93,812 | $3.48M |
| Boothbay Fund Management, LLC | 6,826 | $253.0K |
| Geneos Wealth Management Inc. | 4,250 | $163.0K |
| Sphera Funds Management Ltd. | 4,235 | $157.0K |
| Cubist Systematic Strategies, LLC | 500 | $19.0K |
| Harbour Investments, Inc. | 25 | $1.00K |
Not filed for Q4 2021 yet (1)
Institutions that held Immunocore Holdings plc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 25,144 | $932.0K |